A recent study says that changes in cerebrospinal fluid levels can help predict risk of Alzheimer's disease (AD).
They found that cerebrospinal fluid levels of AB42 appear to be decreased at least five to 10 years before some patients with mild cognitive impairment develop AD dementia whereas other spinal fluid levels seem to be later markers of disease.
The researchers suggested that disease-modifying therapies, such as immunotherapy, are more likely to be successful if started in the early stages of the disease....
A recent study says that changes in cerebrospinal fluid levels can help predict risk of Alzheimer's disease (AD).
They found that cerebrospinal fluid levels of AB42 appear to be decreased at least five to 10 years before some patients with mild cognitive impairment develop AD dementia whereas other spinal fluid levels seem to be later markers of disease.
The researchers suggested that disease-modifying therapies, such as immunotherapy, are more likely to be successful if started in the early stages of the disease....